Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer

[1]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[2]  Akhilesh Pandey,et al.  Identification of differentially expressed serum proteins in gastric adenocarcinoma. , 2015, Journal of proteomics.

[3]  H. Brenner,et al.  Systematic review: Serum autoantibodies in the early detection of gastric cancer , 2015, International journal of cancer.

[4]  J. Liu,et al.  Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma. , 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[5]  David M. Rocke,et al.  The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer. , 2015, EuPA open proteomics.

[6]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[7]  Gary S Collins,et al.  Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.

[8]  Mārcis Leja,et al.  Implementation of gastric cancer screening - the global experience. , 2014, Best practice & research. Clinical gastroenterology.

[9]  I. Choi.  Endoscopic Gastric Cancer Screening and Surveillance in High-Risk Groups , 2014, Clinical endoscopy.

[10]  V. Goh,et al.  Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  Shengyong Fu,et al.  The diagnostic value of monoclonal gastric cancer 7 antigen: a systematic review with meta-analysis , 2014, Clinical and Experimental Medicine.

[12]  R. Hunt,et al.  Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials , 2014, BMJ : British Medical Journal.

[13]  H. Brenner,et al.  Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer. , 2014, Cancer letters.

[14]  W. Guan,et al.  Identification of Circulating MicroRNAs as Novel Potential Biomarkers for Gastric Cancer Detection: A Systematic Review and Meta-Analysis , 2014, Digestive Diseases and Sciences.

[15]  L. Dai,et al.  Evaluation of Diagnostic Value in Using a Panel of Multiple Tumor-Associated Antigens for Immunodiagnosis of Cancer , 2014, Journal of immunology research.

[16]  I. König,et al.  Challenges in planning and conducting diagnostic studies with molecular biomarkers , 2013, Deutsche Medizinische Wochenschrift.

[17]  A. Ziegler,et al.  Herausforderungen an die Planung und Durchführung von Diagnosestudien mit molekularen Biomarkern , 2013, Deutsche Medizinische Wochenschrift.

[18]  Pia Kvistborg,et al.  The cancer antigenome , 2012, The EMBO journal.

[19]  Y. Bahk,et al.  Tumor-associated autoantibodies as diagnostic and prognostic biomarkers , 2012, BMB reports.

[20]  X. Chen,et al.  Serum anti-AEG-1 auto-antibody is a potential novel biomarker for malignant tumors. , 2012, Oncology letters.

[21]  P. Boyle,et al.  EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays , 2012, Tumor Biology.

[22]  P. Wagner,et al.  New paradigms in translational science research in cancer biomarkers. , 2012, Translational research : the journal of laboratory and clinical medicine.

[23]  Ronald J. Faber,et al.  Missing the Mark , 2011 .

[24]  Lizzie Buchen.  Cancer: Missing the mark , 2011, Nature.

[25]  Xi Chen,et al.  A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. , 2011, European journal of cancer.

[26]  Joshua Labaer,et al.  Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. , 2011, Journal of proteome research.

[27]  Andrea Murray,et al.  Immunobiomarkers in Small Cell Lung Cancer: Potential Early Cancer Signals , 2010, Clinical Cancer Research.

[28]  E. Diamandis.  Commentary Cancer Biomarkers: Can We Turn Recent Failures into Success? , 2022 .

[29]  H. Brenner,et al.  Protection from colorectal cancer after colonoscopy: Population-based case-control study , 2010 .

[30]  T. Azuma,et al.  Prescreening of a High-Risk Group for Gastric Cancer by Serologically Determined Helicobacter pylori Infection and Atrophic Gastritis , 2010, Digestive Diseases and Sciences.

[31]  N. Halama,et al.  Seromic profiling of ovarian and pancreatic cancer , 2010, Proceedings of the National Academy of Sciences.

[32]  H. Brenner,et al.  Quantitative Immunochemical Fecal Occult Blood Testing for Colorectal Adenoma Detection: Evaluation in the Target Population of Screening and Comparison With Qualitative Tests , 2010, The American Journal of Gastroenterology.

[33]  H. Brenner,et al.  Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. , 2009, Cancer research.

[34]  M. Sánchez-Carbayo,et al.  Identification of Tumor-associated Autoantigens for the Diagnosis of Colorectal Cancer in Serum Using High Density Protein Microarrays* , 2009, Molecular & Cellular Proteomics.

[35]  H. Brenner,et al.  Comparative Evaluation of Immunochemical Fecal Occult Blood Tests for Colorectal Adenoma Detection , 2009, Annals of Internal Medicine.

[36]  H. Brenner,et al.  Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff‐value , 2007, International journal of cancer.

[37]  Virginia Gewin,et al.  Missing the mark , 2007, Nature.

[38]  H. Brenner,et al.  Case-Control Study Supports Extension of Surveillance Interval After Colonoscopic Polypectomy to at Least 5 Yr , 2007, The American Journal of Gastroenterology.

[39]  Johannes B Reitsma,et al.  Evidence of bias and variation in diagnostic accuracy studies , 2006, Canadian Medical Association Journal.

[40]  Markus F Templin,et al.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. , 2005, Clinical chemistry.

[41]  J Chang-Claude,et al.  Does a negative screening colonoscopy ever need to be repeated? , 2005, Gut.

[42]  Debashis Ghosh,et al.  Autoantibody signatures in prostate cancer. , 2005, The New England journal of medicine.

[43]  H. Brenner,et al.  Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? , 2004, American journal of epidemiology.

[44]  M. Pawlita,et al.  A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. , 2001, Journal of immunological methods.

[45]  L. Brown,et al.  Interval Estimation for a Binomial Proportion , 2001 .

[46]  藤倉雄二,et al.  わが国における成人市中肺炎原因微生物についてのsystematic review/meta‐analysis , 2016 .

[47]  D. Schadendorf,et al.  Prognostic significance of spontaneous antibody responses against tumor‐associated antigens in malignant melanoma patients , 2015, International journal of cancer.

[48]  J. Jett,et al.  udit of the autoantibody test , EarlyCDT ®-Lung , in 1600 patients : n evaluation of its performance in routine clinical practice , 2014 .

[49]  D. Cunningham,et al.  Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[50]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[51]  H. Shimada,et al.  Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association , 2013, Gastric Cancer.

[52]  P. Malfertheiner,et al.  Tumor‐associated autoantibody signature for the early detection of gastric cancer , 2013, International journal of cancer.

[53]  M. Bissell.  Low-Dose Aspirin Use and Performance of Immunochemical Fecal Occult Blood Tests , 2012 .

[54]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[55]  J. Simpson,et al.  Myocardial Infarction and Risk of Suicide: A Population-Based Case-Control Study , 2010, Circulation.

[56]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[57]  K. Carsky.  [Prevention of gastric cancer]. , 1954, Lekarsky obzor.